VERTEX PHARMACEUTICALS INC / MA Cash & Short-Term Investments 2007-2026 | VRTX
Beta
What is VERTEX PHARMACEUTICALS INC / MA's current cash & short-term investments?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual cash & short-term investments for 2025 was $6.61B, a 8.05% increase from 2024. VERTEX PHARMACEUTICALS INC / MA cash & short-term investments for the quarter ending March 31, 2026 was $7.25B.
What was VERTEX PHARMACEUTICALS INC / MA's cash & short-term investments in 2024?
VERTEX PHARMACEUTICALS INC / MA annual cash & short-term investments for 2024 was $6.12B, a 45.48% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's cash & short-term investments in 2023?
VERTEX PHARMACEUTICALS INC / MA annual cash & short-term investments for 2023 was $11.22B, a 4.08% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year cash & short-term investments CAGR?
VERTEX PHARMACEUTICALS INC / MA cash & short-term investments grew at a compound annual growth rate (CAGR) of 0.15% from FY2020 to FY2025, going from $6.66B to $6.61B over 5 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-0.2%
FY2020
$6.66B
→
FY2025
$6.61B
07080910111213141516171819202122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $6.61B | +8.0% | 10-K |
| FY2024 | $6.12B | -45.5% | 10-K |
| FY2023 | $11.22B | +4.1% | 10-K |
| FY2022 | $10.78B | +43.2% | 10-K |
| FY2021 | $7.52B | +13.0% | 10-K |
| FY2020 | $6.66B | +74.9% | 10-K |
| FY2019 | $3.81B | +20.2% | 10-K |
| FY2018 | $3.17B | +51.7% | 10-K |
| FY2017 | $2.09B | +45.6% | 10-K |
| FY2016 | $1.43B | +37.6% | 10-K |
| FY2015 | $1.04B | -24.8% | 10-K |
| FY2014 | $1.39B | -5.3% | 10-K |
| FY2013 | $1.47B | +10.9% | 10-K |
| FY2012 | $1.32B | +36.4% | 10-K |
| FY2011 | $968.9M | -6.1% | 10-K |
| FY2010 | $1.03B | -19.7% | 10-K |
| FY2009 | $1.28B | +230.2% | 10-K |
| FY2008 | $389.1M | +9.4% | 10-K |
| FY2007 | $355.7M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →